PAA
Peregrine Asset Advisers Portfolio holdings
AUM
$321M
This Quarter Return
-3.85%
1 Year Return
+39.23%
3 Year Return
+163.27%
5 Year Return
+302.43%
10 Year Return
+1,799.83%
AUM
$98.1M
AUM Growth
+$98.1M
(-27%)
Cap. Flow
-$42.5M
Cap. Flow
% of AUM
-43.29%
Top 10 Holdings %
Top 10 Hldgs %
52.69%
Holding
119
New
9
Increased
30
Reduced
27
Closed
34
Top Buys
| 1 |
FedEx
FDX
|
$5.11M |
| 2 |
Amgen
AMGN
|
$3.81M |
| 3 |
Workday
WDAY
|
$2.76M |
| 4 |
Nike
NKE
|
$2.14M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
$2.06M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$6.42M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
$5.3M |
| 3 |
Amazon
AMZN
|
$4.74M |
| 4 |
SBNY
Signature Bank
SBNY
|
$4.55M |
| 5 |
Fidelity Nasdaq Composite Index ETF
ONEQ
|
$4.15M |
Sector Composition
| 1 | Technology | 18.29% |
| 2 | Healthcare | 17.49% |
| 3 | Consumer Discretionary | 13.61% |
| 4 | Industrials | 8.3% |
| 5 | Communication Services | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Fidelity Nasdaq Composite Index ETF
ONEQ
$8.5B
| – | – |
-21,161
| Closed | -$4.15M |
|
102
Netflix
NFLX
$521B
| – | – |
-494
| Closed | -$325K |
|
103
Ligand Pharmaceuticals
LGND
$3.25B
| – | – |
-2,100
| Closed | -$212K |
|
104
iShares Biotechnology ETF
IBB
$5.68B
| – | – |
-585
| Closed | -$216K |
|
105
Eaton
ETN
$134B
| – | – |
-47,994
| Closed | -$3.24M |
|
106
Eversource Energy
ES
$23.5B
| – | – |
-11,000
| Closed | -$556K |
|
107
EPAM Systems
EPAM
$9.69B
| – | – |
-7,200
| Closed | -$513K |
|
108
Deutsche Bank
DB
$67B
| – | – |
-44,500
| Closed | -$1.55M |
|
109
CyberArk
CYBR
$23B
| – | – |
-18,650
| Closed | -$1.04M |
|
110
Cigna
CI
$80.2B
| – | – |
-5,853
| Closed | -$948K |
|
111
Berkshire Hathaway Class B
BRK.B
$1.08T
| – | – |
-1,820
| Closed | -$248K |
|
112
BlackRock Floating Rate Income Trust
BGT
$319M
| – | – |
-12,000
| Closed | -$156K |
|
113
Arista Networks
ANET
$173B
| – | – |
-2,750
| Closed | -$225K |
|
114
AerCap
AER
$22.2B
| – | – |
-39,370
| Closed | -$2.93M |
|
115
AbbVie
ABBV
$374B
| – | – |
-9,450
| Closed | -$635K |
|
116
Biogen
BIIB
$20.8B
| – | – |
-3,100
| Closed | -$1.25M |
|
117
Baidu
BIDU
$33.1B
| – | – |
-1,070
| Closed | -$213K |
|